Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letter   |    
Kenneth Duckworth; Michael J. Fitzpatrick
Psychiatric Services 2008; doi:
text A A A

In Reply: The history of care for people with serious mental illness in the United States has been one of broken promises. Dr. Torrey has done more to expose this shameful history than anyone else. In so doing, he has become a true hero to NAMI members throughout the country. Thus it is surprising that Dr. Torrey would suggest that monies saved by prescribing first-generation rather than second-generation antipsychotic medications would be reinvested into more community mental health services. If this were so, then the dollars saved in recent years through downsizing and closing state hospitals should have translated into more community services. Sadly, this has not happened. Rather, states have taken these dollars and reinvested them in roads, prisons—anything but services for people with serious mental illness.

Dr. Torrey points out that NAMI receives contributions from the pharmaceutical industry. However, this does not mean that NAMI's advocacy agenda is driven by these contributions. NAMI has advocated consistently over many years to protect access to a wide range of treatment and services for people with serious mental illnesses, including antipsychotic medications. This position has solid grounding in science. Antipsychotic medications are not interchangeable. A medication that works for one person may not work for another. Thus, for people with schizophrenia and related disorders, a wide range of medications must be available so that clinicians can make informed choices in partnership with their patients about what works best.

Public education advocates would not argue among themselves about whether to prioritize funding for teachers or textbooks. Advocates for people with serious mental illness should similarly not argue over whether funding for medications or case management should be prioritized. Both are desperately needed.




CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe

Related Content
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 22.  >
The American Psychiatric Publishing Textbook of Substance Abuse Treatment, 4th Edition > Chapter 38.  >
Gabbard's Treatments of Psychiatric Disorders, 4th Edition > Chapter 22.  >
APA Practice Guidelines > Chapter 0.  >
The American Psychiatric Publishing Textbook of Geriatric Psychiatry, 4th Edition > Chapter 17.  >
Topic Collections
Psychiatric News
APA Guidelines